Alternative conformations of a major antigenic site on RSV F
Journal Article
·
· PLoS Pathogens
- Geisel School of Medicine at Dartmouth, Hanover, NH (United States); Univ. of Texas, Austin, TX (United States)
- Geisel School of Medicine at Dartmouth, Hanover, NH (United States); Adimab LLC, Lebanon, NH (United States)
- Geisel School of Medicine at Dartmouth, Hanover, NH (United States)
- Humabs BioMed SA, Bellinzona (Switzerland)
- Univ. of Texas, Austin, TX (United States)
- Vanderbilt Univ., Nashville, TN (United States)
The respiratory syncytial virus (RSV) fusion (F) glycoprotein is a major target of neutralizing antibodies arising from natural infection, and antibodies that specifically bind to the prefusion conformation of RSV F generally demonstrate the greatest neutralization potency. Prefusion-stabilized RSV F variants have been engineered as vaccine antigens, but crystal structures of these variants have revealed conformational differences in a key antigenic site located at the apex of the trimer, referred to as antigenic site Ø. Currently, it is unclear if flexibility in this region is an inherent property of prefusion RSV F or if it is related to inadequate stabilization of site Ø in the engineered variants. Therefore, we set out to investigate the conformational flexibility of antigenic site Ø, as well as the ability of the human immune system to recognize alternative conformations of this site, by determining crystal structures of prefusion RSV F bound to neutralizing human-derived antibodies AM22 and RSD5. Both antibodies bound with high affinity and were specific for the prefusion conformation of RSV F. Crystal structures of the complexes revealed that the antibodies recognized distinct conformations of antigenic site Ø, each diverging at a conserved proline residue located in the middle of an α-helix. These data suggest that antigenic site Ø exists as an ensemble of conformations, with individual antibodies recognizing discrete states. Collectively, these results have implications for the refolding of pneumovirus and paramyxovirus fusion proteins and should inform development of prefusion-stabilized RSV F vaccine candidates.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- NIGMS; USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23)
- Grant/Contract Number:
- AC02-06CH11357; AC02-98CH10886
- OSTI ID:
- 1591911
- Alternate ID(s):
- OSTI ID: 1689440
- Journal Information:
- PLoS Pathogens, Journal Name: PLoS Pathogens Journal Issue: 7 Vol. 15; ISSN 1553-7374
- Publisher:
- Public Library of ScienceCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes
|
journal | August 2019 |
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
|
journal | September 2019 |
Antibody Epitopes of Pneumovirus Fusion Proteins
|
journal | November 2019 |
Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition
|
journal | March 2020 |
Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus
|
journal | September 2019 |
Similar Records
Protection of calves by a prefusion-stabilized bovine RSV F vaccine
Transient opening of trimeric prefusion RSV F proteins
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
Journal Article
·
Tue Mar 07 19:00:00 EST 2017
· npj Vaccines
·
OSTI ID:1352244
Transient opening of trimeric prefusion RSV F proteins
Journal Article
·
Tue May 07 20:00:00 EDT 2019
· Nature Communications
·
OSTI ID:1561315
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
Journal Article
·
Mon Feb 06 23:00:00 EST 2012
· Proc. Natl. Acad. Sci. USA
·
OSTI ID:1026529